Gotta et al. have investigated the clearance of leukemia mutated alleles between diagnosis and before hematopoietic cell transplantation and observed that mutations in DNMT3A, TET2, and JAK2 were less likely to be cleared than NPM1, IDH1/IDH2, and FLT3-ITD [140]. The gene discussed is TET2; the disease is leukemia.